Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) EPS (Weighted Average and Diluted): 2010-2025

Historic EPS (Weighted Average and Diluted) for Niagen Bioscience (NAGE) over the last 9 years, with Sep 2025 value amounting to $0.05.

  • Niagen Bioscience's EPS (Weighted Average and Diluted) rose 150.00% to $0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.24, marking a year-over-year increase of 2019.81%. This contributed to the annual value of $0.11 for FY2024, which is 257.14% up from last year.
  • Niagen Bioscience's EPS (Weighted Average and Diluted) amounted to $0.05 in Q3 2025, which was up 25.00% from $0.04 recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's EPS (Weighted Average and Diluted) ranged from a high of $0.09 in Q4 2024 and a low of -$0.13 during Q3 2021.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was $0.00 (2023), whereas its average is $0.02.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first slumped by 85.71% in 2021, then surged by 20,249.07% in 2025.
  • Over the past 5 years, Niagen Bioscience's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.07 in 2021, then soared by 71.43% to -$0.02 in 2022, then soared by 107.60% to $0.00 in 2023, then soared by 5,819.87% to $0.09 in 2024, then surged by 150.00% to $0.05 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $0.05 for Q3 2025, versus $0.04 for Q2 2025 and $0.06 for Q1 2025.